CAS 157013-85-9

7H-Pyrrolo[2,3-d]pyrimidine, 6,7-dimethyl-2,4-di-1-pyrrolidinyl-, hydrochloride (1:1)

CAS : 157013-85-9

Formule : C₁₆H₂₄ClN₅

Masse moléculaire : 321.8483

Ref: IN-DA001P5E

U 89843a

CAS : 157013-85-9

U 89843a is a GABA receptor modulator that is used as an adjunct therapy for the treatment of epilepsy. It has been shown to increase the number of GABA receptors in the brain and reduce seizures in animal models. U 89843a is also used to study the physiology and function of gamma-aminobutyric acid (GABA) receptors, which are found in most parts of the body including the central nervous system. The drug activates GABA receptors by binding to its subunit, which results in a decrease in neuronal excitability and an increase in inhibitory neurotransmission. This agent has also been shown to have a specific effect on acid-sensitive GABAA receptor sites and may be useful for treating conditions such as peptic ulcers and gastroesophageal reflux disease.

Formule : C₁₆H₂₄ClN₅

Degré de pureté : Min. 95%

Masse moléculaire : 321.8 g/mol

Ref: 3D-HGA01385

U-89843A

CAS : 157013-85-9

U-89843A is an allosteric modulator of the GABA_A receptor, known to enhance GABA-induced Cl^- currents [1].

Formule : C₁₆H₂₄ClN₅

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 321.85

Ref: TM-T78560